Special Issue:

Advancements in Animal Health and Production in Low and Middle-Income Countries

Gallic Acid and Olive oil Ameliorate Atherosclerosis in Experimentally Induced in Male Rats

Ghadeer D. Dnan, Hassan K. Al-Awadi, Ali I. Al-AMeedi*

Department of Physiology and Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qasim Green University, Babylon 51013, Iraq.

Abstract | Common cardiovascular illnesses include atherosclerosis, where small aggregations of cholesterol and other components, similar to tiny tumors, develop in the artery wall and subsequently affect blood flow. The current study aimed to investigate the antiatherogenic effects of a combination of olive oil and gallic acid. Forty male atherogenic rats were arbitrarily divided into five groups (n=8). One group was given 1 mL of distilled water as a control (G1), while groups G2 and G3 were treated with 1 mL of Olive oil and 100 mg/kg body weight of Gallic acid, respectively. In addition to G4, which received 40mg/kg body weight of Atorvastatin, and G5, which served as a combination group, the animals were treated with the same dose of G2 and G3 together for 30 consecutive days. Gas chromatography-mass spectrometry (GC-MS) is used to evaluate the phytoconstituents of Olive oil. The results revealed reasonable quantities of unsaturated fatty acids (oleic, palmitic, linoleic, and linolenic acids, among others), which possess cardioprotective and antioxidant properties. The lipid profile indicated that the groups supplemented with Olive oil, Gallic acid, and the combination were significantly improved. Similarly, Atherosclerosis was revealed by increased TC, LDL-C, TG, and VLDL-C, but decreased HDL levels in the G1 group. The results of the G4 and G5 groups showed the best improvement. Similarly, the levels of TNF-α in rats with atherosclerosis were significantly elevated (P < 0.05) compared to those after treatment. The best improvement in TNF-α was observed in G4, which underwent intubation with 40 mg/kg body weight of Atorvastatin. In conclusion, the results suggest that Olive oil and Gallic acid exhibit potential antiatherogenic effects; however, further investigation may be necessary to optimize their therapeutic benefits.

Keywords | Gallic acid, Olive oil, Atherosclerosis, Rat, and Atorvastatin


Received | July 18, 2025; Accepted | September 07, 2025; Published | September 15, 2025

*Correspondence | Ali I. Al-AMeedi, Department of Physiology and Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qasim Green University, Babylon 51013, Iraq; Email: [email protected]

Citation | Dnan GD, Al-Awadi HK, Al-AMeedi AI (2025). Gallic acid and olive oil ameliorate atherosclerosis in experimentally induced in male rats. J. Anim. Health Prod. 13(s1): 422-427.

DOI | https://dx.doi.org/10.17582/journal.jahp/2025/13.s1.422.427

ISSN (Online) | 2308-2801

Copyright: 2025 by the authors. Licensee ResearchersLinks Ltd, England, UK.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).



Introduction

Still, cardiovascular disease (CVD) is the primary cause of death worldwide (Kaminsky et al., 2022). Atherosclerosis and atherosclerotic disorders continue to be the most serious issues in modern medicine and health care, including myocardial infarction, stroke, sudden death, and other prevalent causes of mortality and disability. Atherosclerotic lesion formation has a long asymptomatic period (Jebari-Benslaiman et al., 2022). Thus, in many situations, the initial clinical signs of atherosclerosis emerge when the lesion is already well-formed, causing significant narrowing of the arterial lumen. Atherosclerosis is the predominant pathological mechanism involved in the majority of cases (Fan and Watanabe, 2022). Pathological changes to the artery wall layers, known as atherosclerosis, begin to develop in childhood and often remain unnoticed for many years until they progress to a more advanced stage (Bonafiglia et al., 2022). Multiple atherosclerosis animal models demonstrate that the onset of inflammation coincides with the initiation of lipid accumulation in the arterial wall. In both animals and humans, the first lesions of atherosclerosis are populated by blood leukocytes, which play a crucial role in host defense and inflammation (Soehnlein and Libby, 2021; Ali et al., 2024; Al-Sailawi et al., 2024). New insights into the processes underlying leukocyte recruitment have been gained by applying the fundamental principles of inflammatory biology to atherosclerosis (Ajoolabady et al., 2024). Polyphenols, such as those found in Olive oil (OO), have antioxidant effects by reducing the levels of free radicals; they can also help improve patients’ inflammatory and lipidemic profiles. The antioxidative polyphenols in Olive oil effectively neutralize free radicals that contribute to the oxidation of low-density lipoprotein cholesterol. Consumption of OO is linked to the primary or secondary prevention of cardiovascular illnesses, according to recent studies. Still unclear, however, is whether a lower dosage of OO with a higher concentration of polyphenols or a higher dosage of OO with a lower concentration would be preferable (Kourek et al., 2024). Trihydroxybenzoic acid, also known as Gallic acid, is present in certain plant materials and tea leaves. In both animal and laboratory studies, Gallic acid has been shown to mitigate the effects of transverse aortic constriction (TAC) on heart hypertrophy, dysfunction, and fibrosis. The end-diastolic and end-systolic diameters of the left ventricle are decreased, and the diminished fractional shortening in TAC is recovered (Ayad et al., 2021). Furthermore, it reduces the production of skeletal α-actin, β-myosin heavy chain, brain natriuretic peptide, and atrial natriuretic peptide. Gallic acid administration diminishes perivascular fibrosis (as measured by Trichrome II Blue staining) and connective tissue growth factor and collagen type I expression (Okafor et al., 2024). In this study, we report the effect of Olive oil and Gallic acid on cardiac dysfunction in a rat model of atherosclerosis and compare these effects with those of Atorvastatin.

Materials and Methods

Chemicals

Olive oil purchased from the herbal store (Al-Hikma) at Babylon city, as well as Gallic acid obtained from Sigma Aldrich (USA), cholesterol, Hydrogen peroxide, and Tritone (Biokemica-India).

Gas chromatography-mass spectrometry (GC-MS) analysis

The GC-MS analysis of Olive oil was conducted using an Agilent 7820A GC system connected to a mass spectrometer (Agilent, USA), as shown in Figure 1. The analytical column employed was an Agilent HP-5 MS Ultra Inert (30 mm × 250μm × 0.25 μm). A one μL injection volume was used with a pressure of 11.933 psi. The GC inlet line, auxiliary heaters, and injector (splitless) temperatures were set at 250 °C, 300 °C, and 250 °C, respectively. The carrier gas used was helium with a purity of 99.99%. The oven program temperature included four ramps: the first ramp was held at 60 °C for 3 minutes, the second ramp increased from 60 °C to 180 °C at a rate of 7 °C/min, the third ramp increased from 180 °C to 280 °C at a rate of 8 °C/min, and the fourth ramp was held at 280 °C for 3 min.

Experimental animals and management

The male albino rats utilized in this investigation (n=40) were acquired from the animal house of the College of Veterinary Medicine/University of Al-Qasim. The rats were at least 2 months old and weighed 180-200 g. The rats were provided with tap water and a standard pellet diet. For the first two weeks, the animals were housed in the College of Veterinary Medicine’s animal house at the University of Al-Qasim. They were kept in a controlled environment with a 12-hour light-dark cycle, temperatures ranging from 20°C to 25°C, and air conditioning. Mulch was added to the bed twice weekly.

Induction of atherosclerosis

Forty rats were used to induce atherosclerosis by administering 0.5% hydrogen peroxide in their drinking water and a high-cholesterol diet (1.50% cholesterol) daily for three weeks. Additionally, a single dose of Triton (10 mg/kg) was administered intraperitoneally at the end of the last three weeks of the experiment. After the end of the periods, the levels of cholesterol were estimated to ensure the disease was induced (Pashaie et al., 2017).

Experimental design

After the induction of atherosclerosis, the animals were divided into five groups (n=8), and the rats were divided equally into five treatment groups according to the following:

Lipid profile assessments

Tests for total cholesterol, triglycerides, and HDL-cholesterol were conducted using Randox kits, manufactured by Randox Laboratories Ltd. in Antrim, UK. Lipoprotein cholesterol and extremely low-density lipoprotein cholesterol levels were determined using the Friedewald et al. (1972) method.

Tumor necrosis factor

In the present study, an ELISA kit was used to measure the serum levels of tumor necrosis factor, following the manufacturer’s instructions. The absorbance at 450 nm was tested using a microplate ELISA (Aboktifa et al., 2025).

Statistical analysis

The data from the second experiment were analyzed statistically using one-way and two-way ANOVA, and the least significant differences (LSD) test was employed to determine whether there were substantial differences in the group means. SAS (Statistical Analysis System, version 9.1) was used for this purpose. Statistical significance was determined when the p-value was less than 0.05, and the findings were presented as the mean plus or minus the standard error.

Results and Discussion

The fatty acid compositions of olive oil and other vegetable oils can be studied, and any adulteration detected using GC-MS. Table 2 displays the contents and composition of Olive oil as determined by GC-MS analysis (Figure 1). Oleic acid, a monounsaturated fatty acid, was found to compose 59.51% of the thirteen fatty acid methyl esters that were discovered. According to Table 1 and Figure 1, the area percentages of palmitic acid, linalic acid, linolenic acid, cis-11-docosanoic acid, and eicosanoic acid were 14.10%, 8.61%, 3.37%, 3.17%, and 2.95%, respectively.

 

Lipid profile

The results, as illustrated in Table 2, indicated that the groups supplemented with Olive oil, Gallic acid, and the combination (Olive+Gallic) in the present study showed significant improvements. Similarly, Atherosclerosis, revealed by increased TC (76.92 ± 1.35 mg/dL), LDL-C (58.38 ± 1.31 mg/dL), TG (43.75 ± 1.57 mg/dL), and VLDL-C (10.34 ± 0.11 mg/dL) but decreased HDL (11.54 ± 2.48 mg/dL) levels in the control group. These alterations were markedly ameliorated when the rats were treated with Gallic acid, Olive oil, Atorvastatin, and a combination of these (Table 1). The results of the G4 and G5 groups showed the best improvement, characterized by a decrease in TC, LDL, TG, and VLDL, and an increase in HDL.

 

Table 1: Phytoconstituents of olive oil.

Biological activity

Name

Area %

Retention time (min)

Anti-inflammatory

Palmitic acid, methyl ester

14.10

31.829

Antioxidant

cis-10-Heptadecenoic acid, methyl ester

1.61

32.291

Antibacterial

Oleic acid methyl ester

59.51

33.428

Cardioprotective

Linoleic acid, methyl ester

8.61

34.175

Cardioprotective

Linolenic acid, methyl ester

3.37

35.982

Anti-inflammatory

Eicosanoic acid, methyl ester

2.95

36.421

Cardioprotective

cis-13-Eicosenoic acid, methyl ester

2.19

36.837

Anti-cancer

Docosanoic acid, methyl ester

1.28

38.182

Anti-inflammatory

cis-11-Eicosenoic acid, methyl ester

٠.82

٣٨.704

Antioxidant

Heneicosanoic acid, methyl ester

0.56

٣٩.144

Anti-cancer

cis-11-Docosanoic acid, methyl ester

3.17

٤٠.342

Antioxidant

Tricosanoic acid, methyl ester

1.10

٤١.541

Antioxidant

Dodecanoic acid, methyl ester

0.73

٤٣.964

 

Table 2: Serum concentrations of lipid profiles.

TC Mean± S.E (mg\dl)

TG Mean± S.E (mg\dl)

HDL Mean± S.E (mg\dl)

LDL Mean± S.E (mg\dl)

VLDL Mean± S.E (mg\dl)

Parameters

Groups

129.06±3.26A

43.75±1.57A

11.54±2.48D

79.87±6.42A

10.34±0.11A

G1(control)

89.51±9.63B

30.40±5.63B

17.28±5.06C

31.83±4.53 B

6.45±1.12B

G2 (Olive oil)

82.27±2.85B

33.69±7.16B

21.75±4.65B

26.45±3.44B

6.57±1.43B

G3 (Gallic acid)

53.74±1.78C

21.43±4.98C

34.06±3.27A

13.27±1.57D

1.48±0.99D

G4 (Atorvastatin)

66.22±10.10C

28.26±6.18 C

25.93±1.85 B

19.07±6.73 C

4.01±2.24 C

G5 (Olive Gallic acid)

18.05

9.61

6.51

7.76

2.32

LSD

 

Different capital letters denote significant differences (P ≤ 0.05) among groups.

 

TNF-α

The results in Table 3 demonstrate that levels of TNF-α (mean ± SE) for rats with induced atherosclerosis were significantly higher (P-value < 0.05) compared to the TNF levels after treatment. After 30 days of treatment, the results for TNF-α in all treated groups (G2, G3, G4, and G5) showed a significant reduction compared to the control group. In addition, there were no significant differences among (G2, G3, and G5), which involved intubation with Olive oil, Gallic acid, and a combination, respectively. In contrast, the best improvement in TNF-α was observed in G4, which underwent intubation with 40 mg/kg body weight of Atorvastatin.

 

Table 3: Proinflammatory cytokine TNF levels.

Groups

TNF At induction Ng/L

TNF after treatment Ng/L

G1(control positive)

241.31±11.34Aa

145.01±8.65Ab

G2 (Olive oil)

219.04±13.00Ba

122.77±10.06Bb

G3 (Gallic acid)

193.80±9.74Ca

117.70±13.77Bb

G4 (Atorvastatin)

211.44±10.58Ba

89.43±10.06Cb

G5 (Olive+ Gallic acid)

185.92±13.65Ca

104.08±7.34Bb

LSD

21.3

 

Among groups, different capital letters indicate a statistically significant difference (P ≤ 0.05). Variegated small letters indicate statistical significance (P≤ 0.05) over time intervals.

 

Discussion

An epidemic of atherosclerotic disease, a risk factor for cardiovascular disease, has been expanding over the past several years. Therefore, the purpose of this research was to determine whether two herbal components, Gallic acid and Olive oil, could help restore the cardiac and lipid profiles to normal following atherosclerosis induction. The high concentration of this monounsaturated v-9 fatty acid in Olive oil is one reason for its health advantages. Numerous studies have found that Olive oil has a higher concentration of unsaturated fatty acids (UFAs), and the present study’s GC-MS analysis results corroborate these findings (Poulli et al., 2006; Abdelrahman et al., 2019). Additionally, numerous studies have shown that Olive oil’s high relative levels of unsaturated fatty acids may make it an even more effective tool in the fight against coronary heart disease (Grundy, 1986; Diraman and Dibeklioglu, 2009; Asık and Özkan, 2011). One class of plant polyphenols called gallotannins includes Gallic acid. Some foods that contain it include blackberries, tea leaves, grapes, fruits, and vegetables (Kawada et al., 2001; Choubey et al., 2015). One example is gallnuts. Antioxidant properties are just one of its many biological effects (Soong and Barlow, 2006). However, there is considerable evidence that GA protects the heart (Appeldoorn et al., 2005; Kee et al., 2014; Jin et al., 2017; Al-Mansury et al., 2021). When calculating risk for coronary heart disease, the total cholesterol/HDL ratio outperforms both total cholesterol and LDL cholesterol values. Treatments combining Gallic acid, Olive oil, and atorvastatin considerably improved HDL levels while lowering total, triglyceride, LDL, and VLDL levels. Table 2 shows that the best lipid profile was achieved by combining Olive oil with Gallic acid (G5). This suggests that there may be a synergistic effect between the two that could be useful in clinical settings for controlling lipid levels and risk of cardiovascular disease the significant change in the lipid profile during experimental atherosclerosis development points to Triton-induced disruptions in lipid metabolism. Approximately 30–40% of dyslipidemia cases are secondary, meaning they are triggered by other medical conditions or medications (Yanai and Yoshida, 2021). Hyperlipidemia, caused by a combination of triton and hydrogen peroxide, occurs when peripheral tissues are unable to absorb plasma lipoproteins high in triacylglycerol. It alters the VLDL-C structure, which slows or prevents its clearance from circulation by blood and tissue lipases, and it exacerbates hyperlipidemia by stimulating the liver to produce more cholesterol (Ayad et al., 2022; Okafor et al., 2024; Abdul-Ameer et al., 2024). The results showed that Gallic acid and Olive oil significantly reduced Triton-induced atherosclerosis. The high concentration of bioactive phytochemicals in the G5 group may explain its notable hypolipidemic effects, which have been associated with anti-atherosclerotic and other pharmacological actions (Vazquez et al., 2019; Akbari, 2020; Okafor et al., 2024; Serreli et al., 2024). Atherosclerosis contributes to the development of tumor necrosis factor-a, a multifunctional proinflammatory cytokine (Bruunsgaard et al., 2000). Therefore, a low ankle-brachial arterial pressure index, indicative of peripheral atherosclerosis, is associated with high TNF-α level in the current investigation following atherosclerosis induction, as shown in Table 3. On the other hand, animals given Gallic acid, Olive oil, or atorvastatin (groups G2, G3, G4, and G5) showed a notable decrease in TNF-α serum level.

Conclusions

The results indicate that Olive oil and Gallic acid showed potential antiatherogenic effects, but may require further exploration to maximize their therapeutic benefits. Further studies could investigate the mechanisms underlying these observations and assess their long-term impact on cardiovascular health.

ACKNOWLEDGEMENTS

Authors appreciate the staff at the Department of Physiology, Biochemistry and Pharmacology, the College of Veterinary Medicine at the Al-Qasim Green University for helping to accomplish this work.

NOVELTY STATEMENT

The novelty of this research lies in investigating the antiatherogenic effects of a combination of olive oil and gallic acid. by analyzing the lipid profile and tumor necrotic factor.

AUTHOR’S CONTRIBUTION

Ghadeer D. Danan conceptualized and designed the study Ali I. Al-ameedi and Hassan K. Al-Awadi participated in the investigation and the drafting of the paper as well as, analyzed and interpreted the data. Ali I Al-ameedi revised the paper critically for intellectual content and approved the final version of the paper to be published. All authors agree to be accountable for all aspects of the work.

Generative AI or AI-assisted Technology Statement

The authors declare that no Genrative AI was used in the creation of this manuscript.

Conflict of interest

The authors have declared no conflict of interest.

References

Abdelrahman MH, Hussain RO, Shaheed DS, AbuKhader M, Khan SA (2019). Gas chromatography-mass spectrometry analysis and in vitro biological studies on fixed oil isolated from the waste pits of two varieties of Olea europaea L. OCL, 26: 28. https://doi.org/10.1051/ocl/2019022

Abdul-Ameer AH, Kzar HH, Al-Awadi HK (2024). Newly synthesized chitosan-stevioside-TPGS nanoparticles (CSdNPs) attenuate the effects of high doses of free stevioside in male rats via inhibition of PRAP-α gene expression. Regulat. Mech. Biosyst., 15(3): 446-452. https://doi.org/10.15421/022463

Aboktifa MA, Al-ameedi AI, Ayad ZM, Mosa AH (2025). Hepatoprotective properties of piperine in experimentally hepatotoxic male rats exposed to carbon tetrachloride (CCl₄). J. Anim. Health Prod., 13(1): 124-128 https://doi.org/10.17582/journal.jahp/2025/13.1.124.128.

Akbari G (2020). Molecular mechanisms underlying Gallic acid effects against cardiovascular diseases: An update review. Avicenna J. Phytomed., 10(1): 11.

Ali AS, Kadhim NA, Rasool EMA, Al-Erjan M, Lahhob QR, Mudhafar M (2024). Harnessing CRISPR-Cas9 gene editing for the eradication of inherited retinal diseases in purebred dogs: A path to preservation and health. J. Anim. Health Prod., 12(Special Issue 1): 145–156.

Al-Mansury S, Chekhyor NH, Jassim AM, Hammod MN, Kadium SA, Enad AH (2021). Comparative study of some new naproxen derivatives on the liver and kidney tissues of mice. J. Hunan Univ. Natl. Sci., 48(9).

Al-Sailawi HA, Hadi AA, Raheem HA, Mudhafar M, Dhahi SJ, Lahhob QR (2024). Impact of serratiopeptidase vs. N-acetyl cysteine (NAC) on skin grafting healing in albino male rabbits. Adv. Anim. Vet. Sci., 12(10): 1941-1947. https://doi.org/10.17582/journal.aavs/2024/12.10.1941.1947

Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., Ren, J. (2024). Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell death & disease, 15(11), 817.

Appeldoorn CC, Bonnefoy A, Lutters BC, Daenens K, van Berkel TJ, Hoylaerts MF, Biessen EA (2005). Gallic acid antagonizes P-selectin–mediated platelet–leukocyte interactions: Implications for the French paradox. Circulation, 111(1): 106-112. https://doi.org/10.1161/01.CIR.0000151307.10576.02

Aşık, H. U., Özkan, G. (2011). Physical, Chemical and Antioxidant Properties of Olive Oil Extracted from Memecik Cultivar. Academic Food Journal/Akademik GIDA.

Ayad ZM, Alameedi AI, Abbas HA, Al-Rubaie LS (2021). Gastroprotective effect of conocarpus erectus plus omega-3 on experimentally induced ulcer in rats. World’s Vet. J., 11(4). https://doi.org/10.54203/scil.2021.wvj87.

Ayad ZM, Obaid MR, Al-Ameedi AI, Al-Hashimi AD (2022). Clinical interaction effect of azithromycin and citalopram in New 2-[2--(4, 5-Di Methoxy Carboxy Phenyl) Azo]-Imidazole (DMCPAI)-metal complexes against nikethamide induce lethal convulsion. J. Pharma. Negative Results, 13(3). https://doi.org/10.47750/pnr.2022.13.03.003

Bonafiglia, Q. A., Bendeck, M., Gotlieb, A. I. (2022). Vascular pathobiology: atherosclerosis and large vessel disease. In Cardiovascular Pathology (pp. 265-306). Elsevier

Bruunsgaard H, Skinhøj P, Pedersen AN, Schroll M, Pedersen B (2000). Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis. Clin. Exp. Immunol., 121(2): 255-260. https://doi.org/10.1046/j.1365-2249.2000.01281.x

Choubey S, Varughese LR, Kumar V, Beniwal V (2015). Medicinal importance of Gallic acid and its ester derivatives: A patent review. Pharma. Patent Anal., 4(4): 305-315. https://doi.org/10.4155/ppa.15.14

Diraman, H., Dibeklioglu, H. (2009). Chemometric characterization and classification of selected freshwater and marine fishes from Turkey based on their fatty acid profiles. Journal of the American Oil Chemists’ Society, 86(3), 235-246.

Fan, J., Watanabe, T. (2022). Atherosclerosis: Known and unknown. Pathology international, 72(3), 151-160.

Field, A., Miles, J. (2010). Discovering statistics using SAS.

Friedewald, W. T., Levy, R. I., Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18(6), 499-502.

Grundy, S. M. (1986). Cholesterol and coronary heart disease: a new era. Jama, 256(20), 2849-2858.

Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Martín, C. (2022). Pathophysiology of atherosclerosis. International journal of molecular sciences, 23(6), 3346.

Jin LI, Lin MQ, Piao ZH, Cho JY, Kim GR, Choi SY, Jeong MH (2017). Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase one or histone deacetylase 2. J. Hyperten., 35(7): 1502-1512. https://doi.org/10.1097/HJH.0000000000001327

Kaminsky, L. A., German, C., Imboden, M., Ozemek, C., Peterman, J. E., Brubaker, P. H. (2022). The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease. Progress in cardiovascular diseases, 70, 8-15.

Kawada M, Ohno Y, Ri Y, Ikoma T, Yuugetu H, Asai T, Fukuda K (2001). Anti-tumor effect of Gallic acid on LL-2 lung cancer cells transplanted in mice. Anti-Cancer Drugs, 12(10): 847-852. https://doi.org/10.1097/00001813-200111000-00009

Kee HJ, Cho SN, Kim GR, Choi SY, Ryu Y, Kim IK, Jeong MH (2014). Gallic acid inhibits vascular calcification through the blockade of BMP2–Smad1/5/8 signaling pathway. Vasc. Pharmacol., 63(2): 71-78. https://doi.org/10.1016/j.vph.2014.08.005

Kourek C, Makaris EL, Zouganeli V, Koudounis G, Magiatis P (2024). Comparing the effects of different extra virgin Olive oil (EVOO) doses and polyphenols concentration on the lipidemic profile and hemodynamic parameters in patients with hyperlipidemia. Eur. J. Prevent. Cardiol., 31(Suppl. 1): zwae175-372. https://doi.org/10.1093/eurjpc/zwae175.372

Malik ZJ, Al-ameedi AI, Ayad ZM, Abdullah M (2021). A comparative study between the effect of synthetic and natural propolis on rabbits skin wound infected by staphylococcus aureus. Adv. Anim. Vet. Sci., 9(8): 1233-1237. https://doi.org/10.17582/journal.aavs/2021/9.8.1233.1237

Oh, P. C., Jang, A. Y., Ha, K., Kim, M., Moon, J., Suh, S. Y., Kang, W. C. (2021). Effect of atorvastatin (10 mg) and ezetimibe (10 mg) combination compared to atorvastatin (40 mg) alone on coronary atherosclerosis. The American Journal of Cardiology, 154, 22-28.

Okafor NR, Adegbamigbe AD, Olofin OO, Josiah SS, Ogundele JO, Olaleye MT, Akinmoladun AC (2024). Biochemical and pharmacological properties of a polyherbal antilipemic tea in chemically induced hyperlipidemia. Sci. Afr., 24: e02239. https://doi.org/10.1016/j.sciaf.2024.e02239

Pashaie B, Hobbenaghi R, Malekinejad H (2017). Anti-atherosclerotic effect of Cynodon dactylon extract on experimentally induced hypercholesterolemia in rats. Vet. Res. Forum, 8(3): 185.

Poulli, K. I., Mousdis, G. A., Georgiou, C. A. (2006). Monitoring olive oil oxidation under thermal and UV stress through synchronous fluorescence spectroscopy and classical assays. Food Chemistry, 117(3), 499-503.

Serreli G, Boronat A, De la Torre R, Rodriguez-Moratò J, Deiana M (2024). Cardiovascular and metabolic benefits of extra virgin olive oil phenolic compounds: Mechanistic insights from in vivo studies. Cells, 13(18): 1555. https://doi.org/10.3390/cells13181555

Soehnlein, O., Libby, P. (2021). Targeting inflammation in atherosclerosis—from experimental insights to the clinic. Nature reviews Drug discovery, 20(8), 589-610.

Soong YY, Barlow PJ (2006). Quantification of Gallic acid and ellagic acid from longan (Dimocarpus longan Lour.) seed and mango (Mangifera indica L.) kernel and their effects on antioxidant activity. Food Chem., 97(3): 524-530. https://doi.org/10.1016/j.foodchem.2005.05.033

Vazquez A, Sanchez-Rodriguez E, Vargas F, Montoro-Molina S, Romero M, Espejo-Calvo JA, Mesa MD (2019). Cardioprotective effect of a virgin Olive oil enriched with bioactive compounds in spontaneously hypertensive rats. Nutrients, 11(8): 1728. https://doi.org/10.3390/nu11081728

Yanai H, Yoshida H (2021). Secondary dyslipidemia: Its treatments and association with atherosclerosis. Glob. Health Med., 3(1): 15-23. https://doi.org/10.35772/ghm.2020.01078